Thanks for the link!
I suppose the requirement of a prescription will inherently restrict sales of Pericoach.
therefore I expect there will be quite some time before we see traction in US sales.
This was expected. the odds were primarily stacked against the company by releasing the app on Android first instead of iOS, seeing how majority of women use Apple products.
Can anybody else hear the crescendo?
DYOR
- Forums
- ASX - By Stock
- ALT
- Analytica featured in March 2015 of Bioshares.
Analytica featured in March 2015 of Bioshares., page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)